Li et al [12] studied over 253 Chinese patients to find the association between serum FGF21 and mortality among patients with CAD. They concluded that high levels of FGF21 in the blood were an independent risk factor for CAD. This evidence concerns the gene FGF21 and coronary artery disorder.